|
JAMA Oncology |
A Case of Multiple Hemorrhagic Friable Nodules |
1 |
Yes |
1/5/2026 |
|
JAMA Oncology |
A Young Man With a Neck Mass and Hypereosinophilia |
1 |
Yes |
10/19/2026 |
|
JAMA Oncology |
Accompanying Patients in the Time of COVID-19 |
1 |
Yes |
6/4/2024 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast CancerA Review |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
An Atypical Rash on the Chest |
1 |
Yes |
12/29/2025 |
|
JAMA Oncology |
An Intramedullary Enigma |
1 |
Yes |
3/31/2025 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease |
1 |
Yes |
8/19/2024 |
|
JAMA Oncology |
Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease |
1 |
Yes |
8/19/2024 |
|
JAMA Oncology |
Anuric Kidney Failure in a Patient With Metastatic Melanoma |
1 |
Yes |
8/19/2024 |
|
JAMA Oncology |
Anuric Kidney Failure in a Patient With Metastatic Melanoma |
1 |
Yes |
8/19/2024 |
|
JAMA Oncology |
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer |
1 |
Yes |
8/30/2024 |
|
JAMA Oncology |
Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer |
1 |
Yes |
8/30/2024 |
